USPTO serial 79103969
CITELINE
Reviewed by CopyMark Law Group
Reg. 4762279Status 706Registered
- Filing date
- Status date
- Registration date
- Jun 30, 2015
- Examiner
- FENNESSY, EDWARD JOHN
- Law office
- TMEG LAW OFFICE 101
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with CITELINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
US
Informa Business Intelligence, Inc.
New York, NY, US
Other trademarks owned by Informa Business Intelligence, Inc.
Wilmington, New Castle County, DE, US
GB
US
PHARMA INTELLIGENCE U.K. LIMITED
London, GB
US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jessica S. Sachs
Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.5445 Corporate DriveSuite 200Troy, MI 48098Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | [ Apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, prerecorded magnetic data carriers featuring information and data in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; blank recording optical discs; pre-recorded CDs, video tapes, laser disks and DVDs featuring information in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; downloadable computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare and manuals in electronic format sold as a unit; computer software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] downloadable electronic publications in the nature of [ newsletters, ] reports, [ directories and bulletins ] in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare from databases or the internet; downloadable electronic publications and information, namely, [ newsletters, ] reports, [ directories and bulletins ] in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare provided on-line from databases or the internet; [ computer programs featuring programming languages in electronic form for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; prerecorded magnetic, electronic or optical data carriers featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] electronic publications, namely, instruction manuals recorded on computer media relating to use of computers and to data, all recorded magnetically, optically or electronically [ ; magnetic, optical and electronic data recording apparatus for recording of sound, images or data ] | ACTIVE | — |
| 016 | [ Paper and cardboard; goods made from paper or cardboard not included in other classes, namely, boxes, cartons, storage containers, and packaging containers; printed materials, namely, journals, newsletters, reports, and directories featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; printed instructional materials in the field of computer software and programmes; book-binding material; photographs; stationery; printed instructional, educational, and teaching materials in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare ] | SECTION 71 - CANCELLED | — |
| 041 | Education services, namely, providing educational seminars, [ conferences, classes and workshops ] in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; [ Training services in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; entertainment and recreational services, namely, sporting and cultural events, training and educational conferences, courses, seminars and exhibitions in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Publishing and issuing of scientific papers in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] Electronic publishing services, namely, publication of text and graphic works of others online featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare [ ; the provision of news online in the nature of news agencies, namely, gathering and dissemination of news; Nondownloadable electronic publications in the nature of journals, newsletters, reports, and directories in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare via the Internet ] | ACTIVE | — |
| 042 | [ Medical services; advisory medical services and the provision of medical information; dentistry services; advisory medical services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following the administration of chemical, biological radiological or nuclear materials; providing medical information, consultancy and advisory services in the field of pharmaceuticals; medical information in the field of pharmaceuticals; dispensing of pharmaceuticals; veterinary services; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of medical information relating to surgery; advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy services, namely, medical, hygienic and beauty care services; information, consultancy and advisory services relating to all the aforesaid services; information, consultancy and advisory services ] [ in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare ] [ relating to all the aforesaid services provided on-line] | SECTION 71 - CANCELLED | — |
| 044 | [ Medical services; ] advisory medical services and the provision of medical information; [dentistry services; advisory medical services and the provision of information relating to dentistry; ] advisory services and the provision of information relating to health; [ consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following the administration of chemical, biological radiological or nuclear materials; providing medical information, consultancy and advisory services in the field of pharmaceuticals; medical information in the field of pharmaceuticals; dispensing of pharmaceuticals; veterinary services; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of medical information relating to surgery; advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy services, namely, medical, hygienic and beauty care services; information, consultancy and advisory services relating to all the aforesaid services; ] information, consultancy and advisory services in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare relating to all the aforesaid services provided on-line | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Citeline, Inc.
- Other trademarks owned by Informa Business Intelligence, Inc.
- Other trademarks owned by Caerus US 1 Inc.
- Other trademarks owned by Informa UK Limited
- Other trademarks owned by Citeline, Inc.
- Other trademarks owned by PHARMA INTELLIGENCE U.K. LIMITED
- Other trademarks owned by Citeline, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CITELINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 8, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 8, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 8, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Sep 8, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 2, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| May 30, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 30, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 30, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 30, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 30, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 4, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 29, 2024 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 19, 2024 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 19, 2024 | INPC | INVALIDATION PROCESSED | — |
| Sep 13, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 30, 2024 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Mar 7, 2024 | DCPN | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jan 12, 2024 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jan 12, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 12, 2024 | PRAN | POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED | — |
| Jan 12, 2024 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jan 12, 2024 | PRA7 | REGISTERED - SEC. 7 REQUEST ABANDONED | — |
| Jan 10, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 24, 2023 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Feb 25, 2023 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Feb 7, 2023 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 6, 2022 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Nov 30, 2022 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Jun 7, 2022 | PR75 | POST REGISTRATION ACTION MAILED - SEC. 71 & 15 | — |
| Jun 6, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 29, 2021 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| May 20, 2021 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jun 30, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 26, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 5, 2017 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Aug 4, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 17, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 26, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 26, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 30, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 30, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 14, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 14, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 10, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 25, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 25, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 25, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 6, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 5, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 20, 2015 | ALIE | ASSIGNED TO LIE | — |
| Oct 16, 2014 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jul 16, 2014 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 16, 2014 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 16, 2014 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 8, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 8, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 8, 2014 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 9, 2014 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 9, 2014 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 9, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 23, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 23, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 23, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 28, 2013 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2013 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 28, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 28, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 28, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2013 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 5, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 3, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 3, 2013 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 27, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 27, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 27, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 1, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 31, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 31, 2012 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 8, 2012 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 8, 2012 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 8, 2012 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 6, 2012 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| May 25, 2012 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 25, 2012 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 9, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 9, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 9, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 4, 2012 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Dec 19, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 27, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 11, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 10, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 10, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 10, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 10, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 9, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 8, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 7, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 7, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 3, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |